Skip to main content
Entheon Biomedical Corp. logo

Entheon Biomedical Corp. — Investor Relations & Filings

Ticker · ENBI LEI · 894500N2J7IXCCDRWU50 CSE Professional, scientific and technical activities
Filings indexed 243 across all filing types
Latest filing 2023-04-28 Regulatory Filings
Country CA Canada
Listing CSE ENBI

About Entheon Biomedical Corp.

https://www.entheonbiomedical.com/

Entheon Biomedical Corp. is a biotechnology research and development company focused on creating therapeutic solutions for addiction and substance use disorders. The company specializes in the development and commercialization of psychedelic medicines, particularly dimethyltryptamine (DMT). Entheon aims to progress psychedelics to therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, and novel compounds tailored for treating these complex conditions.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2023-04-28 English
Statement of executive compensation (form 51-102F6V) - English.pdf
Regulatory Filings
2023-04-19 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2023-03-23 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-03-23 English
Annual MD&A - English.pdf
Regulatory Filings
2023-03-23 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.